The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
The AACR has designated this live activity for a maximum of 23.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.
CLAIMING (CME) CREDIT
Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)™ for this live continuing medical education activity must complete the online CME Request for Credit Survey, below. Certificates will only be issued to those who complete the survey. Your CME certificate will be sent to you via email after the completion of the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE AND LEARNING OBJECTIVES
Racial and ethnic disparities in cancer rates are well documented. Research shows that individuals from racial/ethnic minorities and medically underserved populations are more likely to be diagnosed with late-stage diseases that might have been treated more effectively or cured if diagnosed earlier. For example, the rate of new cancer cases in the US is highest among black men, followed by white, Hispanic, Asian/Pacific Islander, and American Indian/Alaska Native men. In comparison, for women, the rate of new cancer cases is highest among white women, followed by black, Hispanic, Asian/Pacific Islander, and American Indian/Alaska Native women. Death rates are highest among black women and men, followed by white, American Indian/Alaska Native, Hispanic, and Asian/Pacific Islander women and men.
Data suggest that access to quality care contributes to disparities in cancer risk, treatment, and survival. Cultural beliefs, as well as financial and physical barriers are some of the issues that prevent individuals or groups from obtaining effective health care. However, other factors also play a major role. Among these factors are the availability of tailored health communications for medically underserved populations, genetics and genomics, multiple chronic conditions, and population differences in diet. Additionally, differences between populations regarding alternative RNA splicing, tumor microenvironment, the incidence of second cancers, and the prevalence of rare cancers all play various roles in cancer risk, treatment, and survival of individuals in medically underserved populations.
To reduce the burden of cancer due to health disparities, there is a need to educate physicians on the role of the various factors involved in creating health disparities and how they impact the diagnosis, treatment, response, and survival of cancer patients from racial/ethnic minorities and medically underserved populations. This conference will bring together a wide range of physicians, scientists, health professionals, and health care leaders to discuss the latest findings in their fields, to foster collaborative interdisciplinary interactions and partnerships, and to stimulate the development of new research and clinical practices aimed to reduce cancer health disparities and provide the most appropriate care for a diverse patient population.
After participating in this CME activity, physicians should be able to:
- Evaluate and implement tools and strategies for tailoring health communications that are appropriate for different racial, ethnic, socioeconomic, and at-risk populations;
- Assess the link between tumor microenvironment, vitamin D, and prostate cancer in diverse populations;
- Identify the impact of multiple chronic conditions in cancer risk, treatment, and survival in underrepresented and medically underserved populations;
- Articulate the role of populations differences in alternative RNA splicing to identify potential druggable drivers of tumor phenotypes to address health disparities;
- Explain the role of second cancers in minority populations and its impact on survivorship;
- Distinguish the promises and pitfalls of precision/personalized medicine in reducing cancer health disparities; and
- Identify factors which impact clinical trials outcomes in patients from different populations.
It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the Program/Proceedings of this conference.
ACKNOWLEDGEMENT OF FINANCIAL OR OTHER SUPPORT
This activity is supported by grants and will be disclosed at the activity.
QUESTIONS ABOUT CME?
Please contact the Office of CME at (215) 440-9300 or firstname.lastname@example.org.